
Sign up to save your podcasts
Or


Daphne Koller, Noubar Afeyan, and Dr. Eric Topol, leaders in AI-driven medicine, discuss how AI is changing biomedical research and discovery, from accelerating drug target identification and biotech R&D to helping pursue the “holy grail” of a virtual cell.
Show notes
By Researchers across the Microsoft research community4.8
8080 ratings
Daphne Koller, Noubar Afeyan, and Dr. Eric Topol, leaders in AI-driven medicine, discuss how AI is changing biomedical research and discovery, from accelerating drug target identification and biotech R&D to helping pursue the “holy grail” of a virtual cell.
Show notes

341 Listeners

154 Listeners

213 Listeners

306 Listeners

90 Listeners

506 Listeners

477 Listeners

59 Listeners

131 Listeners

95 Listeners

123 Listeners

591 Listeners

26 Listeners

35 Listeners

136 Listeners